icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
eNq1mF1P2zAUhu/7K6LcNx+sX0xp0dbBVglEV6g27Qa5ySl1l9rh2C6FXz+nKVuZHAEuvoztvOfE5/XjoyQnm1XurQEF5azvx0Hke8BSnlF22/en12fNnn8yaCRLsiZ7y7pBFMRHvpfmRIi+X84GMyBMBD8vzr+Afh/QHzS8hM+WkMpn65SkefCNiMUFKco1XrLmNPNWIBc86/uFkttRLxESdRaDe46/RUFSSMLdyP7s8qa1P56EpdgrVJUAPCfs1igKzEozVYjA5JBIuOX4YJSepzdHvW4ninpWIaiYgOAKUxgTuRgjX9MMMnMkkguwCjK/z64A1znIMohRPFymK2ElTpZkM4G7kTnpT3p2KDeyGTXjbrsVxVHruBsfd6xC4d5Wmc2jPyLUBTnutHudoxBYKCHVFUR619RFfOQ5fVQrMrMs1ZijJLmjIlExfG43R3EQ7l40Q0ZFkZOHYCkK260iSPQ0oIaCuw8pv+AaNaZyvWf/6TOV5+Ebs57uIOIo45JRQ660H80sOZvYbsSQMwmb+ora4U9udl6kIN5P9pEzM/rHapbT1JZwmkEKhJxORvWAc8iGz0TAFN3B4QdlGb8X7w+d/SI7yr7YctMoWmAW65r0OnG7bX2mfmlH1dw/pwp5AaHGERWHUGbE5vxQvmiTmqWeLOrKndveiKckh5ruqGlJHm3Lp2bOmfHdHapqwij69fTa1i3fFeDD1fbRKE2z/t8622HZBeu1N2sTf7vTqwP/ir651ftgtwkKzTxZSFmIj2G4IKIpiN6oYI6u0b93+bpr4J3c8FXHU+HTUeqz6l58fbFsz91L9/+hPe3u/V3vbIwhUcEBdagQ7Qyko9P3Z/O/htZZ2uNnLHEXZtt8Ekk5c9UFqZlR8bDbQNeVnaGGw+V8Tmv+qdT6Mgmr/zmDRhKW/3IGjT+k3f2P
eeeCXcztR0Pasw1t
Listen
